Pancreatic cancer is a malignancy with a poor prognosis. Its increased incidence was observed in diabetic patients in the past.
However, there is no evidence, whether diabetes is a risk factor for neoplastic transformation, or if it arises secondarily as a result of the tumor. The key is an early detection of cancer to perform pancreatectomy - the only possible curative therapy yet.
This requires early diagnostic markers.